HURC News Alert Hurco Companies (HURC) 38.90 11/13/2014 16:4

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Hurco Companies (HURC) 38.90 $HURC

Wall Street Breakfast: Hasbro In Talks To Buy DreamWorks Animation
Wall Street Breakfast - Seeking Alpha - Thu Nov 13, 5:30AM CST
Economy The U.S and India reached an agreement today on stockpiling of food by governments, clearing a major stumbling block for the implementation of the World Trade Organization's trade facilitation deal that has been stalled for months. The...
HURC: 38.90 (-0.53), SNE: 20.41 (-0.22), INTC: 33.68 (+0.30), GOOG: 545.38 (-1.93), NOAH: 16.97 (+0.03), SPY: 204.19 (+0.23), TRP: 49.64 (-0.72), GOOGL: 556.44 (-1.81), TWC: 141.05 (+4.57), TWTR: 40.04 (-2.50), HMC: 31.53 (+0.34), CSCO: 25.68 (+0.57), BCS: 14.43 (-0.15), HAS: 54.98 (-2.49), FB: 74.25 (-0.47), DWA: 25.52 (+3.15), MHG: 14.82 (unch), BA: 128.53 (+2.66), QQQ: 102.90 (+0.44), ARMH: 41.26 (-0.13), CMCSA: 54.30 (+0.70)

Hurco Cos Has Returned 13.2% Since SmarTrend Recommendation (HURC)
Comtex SmarTrend(R) - Tue Nov 11, 9:29AM CST
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on October 27th, 2014 at $34.94. In approximately 2 weeks, Hurco Cos has returned 13.17% as of today's recent price of $39.54.
HURC: 38.90 (-0.53)

30.5% Return Seen to Date on SmarTrend Hurco Cos Call (HURC)
Comtex SmarTrend(R) - Wed Oct 01, 4:42PM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 5 months, Hurco Cos has returned 30.47% as of today's recent price of $35.84.
HURC: 38.90 (-0.53)

Hurco Cos Shares Up 35.0% Since SmarTrend's Buy Recommendation (HURC)
Comtex SmarTrend(R) - Wed Sep 24, 10:58AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 5 months, Hurco Cos has returned 35.02% as of today's recent price of $37.09.
HURC: 38.90 (-0.53)

Hurco Technology Draws Newcomers at the International Manufacturing Technology Show
GlobeNewswire - Tue Sep 23, 7:00AM CDT
Hurco Companies, Inc. (Nasdaq:HURC) reports that more than 70% of the visitors viewing the company's CNC technology in action at the International Manufacturing Technology Show (IMTS) in Chicago last week were first-time visitors. "The total visitor traffic to our booth and demonstrations, the number of new visitors, and the excitement surrounding Hurco's new technology/product introductions at IMTS exceeded our expectations," said Greg Volovic, President of Hurco.
HURC: 38.90 (-0.53)

Hurco Cos Up 36.5% Since SmarTrend Uptrend Call (HURC)
Comtex SmarTrend(R) - Wed Sep 17, 9:34AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 4 months, Hurco Cos has returned 36.55% as of today's recent price of $37.51.
HURC: 38.90 (-0.53)

Hurco Cos Has Returned 28.6% Since SmarTrend Recommendation (HURC)
Comtex SmarTrend(R) - Wed Sep 10, 9:09AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 4 months, Hurco Cos has returned 28.61% as of today's recent price of $35.33.
HURC: 38.90 (-0.53)

Hurco Companies, Inc. Announces Quarterly Cash Dividend
GlobeNewswire - Wed Sep 10, 7:09AM CDT
Hurco Companies, Inc. (Nasdaq:HURC), an international industrial technology company, announced today that its Board of Directors approved the payment of a cash dividend of $0.07 per share. The dividend will be paid on October 13, 2014, to shareholders of record as of the close of business on September 29, 2014.
HURC: 38.90 (-0.53)

Hurco Reports Third Quarter Results
GlobeNewswire - Fri Sep 05, 8:46AM CDT
Hurco Companies, Inc. (Nasdaq:HURC) today reported net income of $4,375,000, or $0.66 per diluted share, for its third fiscal quarter ended July 31, 2014, compared to $854,000, or $0.13 per diluted share, for the corresponding period in fiscal 2013. For the first nine months of fiscal 2014, Hurco reported net income of $10,280,000, or $1.56 per diluted share, compared to $6,291,000, or $0.96 per diluted share, for the corresponding period in fiscal 2013.
HURC: 38.90 (-0.53)

Hurco Cos Up 21.2% Since SmarTrend Uptrend Call (HURC)
Comtex SmarTrend(R) - Tue Sep 02, 9:46AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 4 months, Hurco Cos has returned 21.22% as of today's recent price of $33.30.
HURC: 38.90 (-0.53)

Hurco Cos Up 15.9% Since SmarTrend Uptrend Call (HURC)
Comtex SmarTrend(R) - Fri Aug 15, 11:06AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 3 months, Hurco Cos has returned 15.85% as of today's recent price of $31.83.
HURC: 38.90 (-0.53)

Shares of HURC Up 14.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 08, 9:53AM CDT
SmarTrend identified an Uptrend for Hurco Cos (NASDAQ:HURC) on May 12th, 2014 at $27.47. In approximately 3 months, Hurco Cos has returned 14.31% as of today's recent price of $31.40.
HURC: 38.90 (-0.53)

Milestones, Financial Results and Conference Call Schedules, and Technical Updates - Research Reports on TriQuint, Tessera Technologies, Pixelworks, Enphase Energy and Hurco
PR Newswire - Thu Jul 24, 8:10AM CDT
Today, Analysts Review released its research reports regarding TriQuint Semiconductor, Inc. (NASDAQ: TQNT), Tessera Technologies Inc. (NASDAQ: TSRA), Pixelworks, Inc. (NASDAQ: PXLW), Enphase Energy, Inc. (NASDAQ: ENPH) and Hurco Companies Inc. (NASDAQ: HURC). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/5057-100free.
ENPH: 10.64 (+0.01), PXLW: 4.95 (-0.17), HURC: 38.90 (-0.53), TQNT: 22.17 (+0.07), TSRA: 31.80 (+0.10)

Hurco Is Working on a Potentially Disruptive 3D Printing Product
at The Street - Thu Jul 17, 2:38PM CDT
Move over 3D Systems and Stratasys. A 46-year-old Hurco has filed a U.S. patent for what may be disruptive technology that combines 3D printing with your basic CNC machine.
HURC: 38.90 (-0.53), DDD: 33.39 (-1.11), XONE: 19.80 (-0.24), SSYS: 101.11 (-0.96)

Why Hurco Companies (HURC) Stock Is Surging Today
at The Street - Tue Jul 15, 1:58PM CDT
Hurco Companies (HURC) stock is soaring after it announced filing a U.S. patent application for new technology it believes could turn a CNC milling machine into a 3D printer.
HURC: 38.90 (-0.53)

Hurco Files CNC-Based 3D Printing U.S. Patent Application
GlobeNewswire - Tue Jul 15, 7:22AM CDT
Hurco Companies, Inc. (Nasdaq:HURC) today announced the company recently filed a U.S. patent application for new technology combining 3D printing and CNC machining.
HURC: 38.90 (-0.53)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Liberty Hill: 50 Years of Grassroots Revolution

Updated Category News Views 4

Half a Century of Community Empowerment You don't see organizations sticking to their guns for fifty years without having something real to offer. Liberty Hill Foundation is celebrating this colossal milestone in style by throwing their weight behind 17 grassroots groups under the 2026 Fund for Change. They're not just tossing money around but are genuinely becoming the...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 6

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Red-Eye Flights Surge, Driven By Western U.S. Routes

Updated Category News Views 5

You can always count on some things staying the same, right? Well, if you thought red-eye flights were going to fade away, think again. These late-night wonders are not just hanging around—they're booming in the west like there's no tomorrow. Literally. Champion Traveler has laid it all out for us: about 115,580 overnight flights in 2025, a record high since this mad...

Continue Reading
Rare Collectibles Highlight Morphy's Auction on Oct 4

Updated Category News Views 2

Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...

Continue Reading
AbbVie's Bold Leap in Menstrual Migraine Treatment

Updated Category News Views 10

AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 3

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
Seismic Pharma Kicks Off Phase 3 Trial for Istaroxime

Updated Category News Views 3

Seismic Sets the Stage for a Medical Milestone From the heart of biotech in Durham, North Carolina, seismic waves ripple through the medical community as Seismic Pharmaceuticals embarks on a high-stakes adventure. It's official: they've enrolled their very first patient in the global Phase 3 trial of istaroxime, targeting the grim specter known as cardiogenic shock. You...

Continue Reading
XKL Delivers MediaLight for High-Speed Optical Transport

Updated Category News Views 2

Unpacking the MediaLight Launch Kicking off September, XKL is tossing its hat in the ring with the MediaLight Xponder and Muxponder systems. These aren't just any run-of-the-mill gizmos—nope, they're touted as top-of-the-line optical transport solutions. The talk of the town is their ability to dish out high-density 100G and 400G transport, and for geeks in the trade,...

Continue Reading
CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 13

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 5

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading

Top 5 Most Recently Viewed Articles

Meiji Seika Pharma Expands KOSTAIVE® Manufacturing In Japan

Updated Category News Views 394

Meiji Seika Pharma Enhances Manufacturing Capabilities Meiji Seika Pharma Co., Ltd., known for its commitment to healthcare, has recently received exciting approval to expand its manufacturing and marketing capabilities for the innovative self-amplifying mRNA vaccine, KOSTAIVE®. This decision marks a significant milestone for the company as it strengthens the local...

Continue Reading
OS Therapies Achieves Milestone in Osteosarcoma Treatment

Updated Category News Views 246

An Exciting Breakthrough in Osteosarcoma Treatment OS Therapies, Inc. (NYSE-A: OSTX), a pioneering biotechnology firm, has recently made waves in the oncology field by completing a Phase 2b clinical trial concerning its innovative treatment, OST-HER2. This trial aims to address the severe challenges faced by patients suffering from lung metastatic osteosarcoma - a rare...

Continue Reading
CEO Andy Byron Takes Leave Following Coldplay Concert Incident

Updated Category News Views 381

CEO Andy Byron Takes Leave Amidst Viral Coldplay Incident Astronomer CEO Andy Byron is currently on leave due to a controversial situation that unfolded during a Coldplay concert. A video that circulated online appears to show Byron embracing the company’s HR head, Kristin Cabot, which ignited a social media frenzy. The Viral Video's Impact The footage, which originated...

Continue Reading
Misunderstood Whiskey's Exciting Launch of Orange Blossom Bourbon

Updated Category News Views 234

Misunderstood Whiskey Launches Orange Blossom Bourbon Misunderstood Whiskey Co. has announced the launch of their eagerly awaited Orange Blossom Bourbon. This marks a significant milestone as it is the brand's first bourbon since it began in 2017. With this release, the company aims to revolutionize the flavored whiskey market by providing high-quality, infused options...

Continue Reading
Impact of Capital Flows on Emerging Markets: A Cautionary Analysis

Updated Category News Views 352

Capital Flow Challenges for Emerging Economies The dynamics of capital flows have become a significant topic of discussion lately, with emerging markets facing potential hurdles that could alter their financial landscape dramatically. Recent insights from JPMorgan, an influential investment bank, shed light on these pressing issues. As economic policies shift globally,...

Continue Reading